About 9D Arrays
Learn more about our mission and vision
Who are we?
9D Arrays is a medical technology startup, supporting medical and healthcare innovations. Our company was founded based on a medical research project.
What is cancer?
Cancer is a disease that abnormal cells develop out of control and spread to other parts of the body. These cells can affect one health, probably leading to death.
What is cancer recurrence?
Cancer recurrence means cancer coming back after treatment. It is difficult to predict whether and when cancer recurs, so 9D Arrays has a mission to improve cancer patient health.
How can we take care of patient health?
9D Arrays built the apps to detect oral cancer and predict recurrence. We provide our clients with a high-quality service that is reliable and able to be trusted for use on patients.
Why develop prediction tools for oral cancer?
According to World Health Organization, more than 389 thousand people were diagnosed with oral cancer globally, and the number of death was about 188 thousand. The recurrence rate of oral cancer can vary between 20% and 86% in the first year after treatments.
How do we help oral cancer patients?
Our apps are launched on cloud to serve everyone globally. Medical professionals can use LNTD to detect oral cancer in histopathology images. For prognosis, MILP was developed based on biomarkers to discriminate the patients with early recurrence from late/no recurrence.
References
- Website citation:
Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [DD Month YYYY]. - Cancer incidence and mortality data:
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021 Feb 4. doi: 10.3322/caac.21660. Epub ahead of print. PMID: 33538338. - Cancer recurrence data:
Blatt, S., Krüger, M., Sagheb, K., Barth, M., Kämmerer, P. W., Al-Nawas, B., & Sagheb, K. (2022). Tumor recurrence and follow-up intervals in oral squamous cell carcinoma. Journal of Clinical Medicine, 11(23), 7061. Sasaki M., Aoki T., Karakida K., Otsuru M., Takahashi M., Akamatsu T., Sakamoto H., Ota Y. Postoperative follow-up strategy in patients with oral squamous cell carcinoma. J. Oral Maxillofac. Surg. 2011;69:e105–e111. doi: 10.1016/j.joms.2010.11.039.
Our Team
Chui Shan is the founder of 9D Arrays. She obtained 7 research and industrial awards, including one from the Hong Kong Cyberport. Ibrahim joins her to develop machine learning models for cancer detection. Chui Shan holds a BSc in Chemistry from the University of Sydney, Australia, and MMedSc in Clinical Physics and PhD in Oncology from the University of Hong Kong. She is registered as a graduate statistian (GradStat) in the Hong Kong Statistical Society.
Ibrahim is the co-founder of 9D Arrays. He has experience in computer engineering and data science. Chui Shan describes him as a great programmer because he is easy to communicate and excellent at programming. Ibrahim holds a BEng in Computer Engineering and MEng in Big Data Analytics from reputable universities in the Middle East.
Oceana has experience in venture capital and management consulting, with a focus on emerging technologies and strategic growth. She is currently a cohort member of the Cyberport Creative Micro Fund (CCMF) in Hong Kong and serves as advisor to Bevatech, a biotechnology startup that won a gold medal in the 2024 iGEM competition. Oceana holds a BA in Economics from Cornell University with a Minor in Business and Music, and is a Certified Financial Risk Manager (FRM). She is fluent in Mandarin, Cantonese, and English. In her leisure time, you will find her throwing kicks at her local Muay Thai gym.